DRD2 and schizophrenia: Such a 7TM receptor, the dopamine D2 receptor (D2R), is central for the treatment of schizophrenia since all antipsychotics in clinical use are able to block this receptor at therapeutical concentrations, albeit differences exist between first- and second-generation drugs.